BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 3.06.2014

Product Development Under the Animal Rule, Revised Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA) is announcing the availability of a revised draft guidance for industry entitled "Product Development Under the Animal Rule." When human efficacy studies are neither ethical nor feasible, FDA may rely on adequate and well-controlled animal efficacy studies to support approval of a drug or licensure of a biological product under the Animal Rule. This revised draft guidance replaces the 2009 draft guidance for industry entitled "Animal Models--Essential Elements to Address Efficacy Under the Animal Rule" and addresses a broader scope of issues for products developed under the Animal Rule. Once finalized, this guidance is intended to help potential sponsors (industry, academia, and government) understand FDA's expectations for product development under the Animal Rule.

Source: Federal Register — Food and Drug AdministrationOpen original release →